Javascript must be enabled to continue!
Fahr’s syndrome: literature review of current evidence
View through CrossRef
Abstract
Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus. Molecular genetics of this disease haven’t been studied extensively; hence evidence at the molecular and genetic level is limited. Fahr’s disease commonly affects young to middle aged adults. Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases. Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others. Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history. Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull. Other investigations include blood and urine testing for hematologic and biochemical indices. Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions. Families with a known history of Fahr’s disease should be counseled prior to conception so that the birth of affected babies can be prevented. This review was written with the aim to remark on the current substantial evidence surrounding this disease.
Springer Science and Business Media LLC
Title: Fahr’s syndrome: literature review of current evidence
Description:
Abstract
Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex.
Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus.
Molecular genetics of this disease haven’t been studied extensively; hence evidence at the molecular and genetic level is limited.
Fahr’s disease commonly affects young to middle aged adults.
Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases.
Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others.
Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history.
Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull.
Other investigations include blood and urine testing for hematologic and biochemical indices.
Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions.
Families with a known history of Fahr’s disease should be counseled prior to conception so that the birth of affected babies can be prevented.
This review was written with the aim to remark on the current substantial evidence surrounding this disease.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Findings of Fahr’s Syndrome in A Patient Suspected With Subarachnoid Hemorrhage: An Evidence-Based Case Report
Findings of Fahr’s Syndrome in A Patient Suspected With Subarachnoid Hemorrhage: An Evidence-Based Case Report
ABSTRACT
Fahr’s syndrome is an entity where there is symmetrical bilateral calcification of basal ganglia with parkinsonian and psychiatric symptoms. However, due to its rari...
Manifestations parkinsoniennes révélant un syndrome de Fahr : à propos d'un cas.
Manifestations parkinsoniennes révélant un syndrome de Fahr : à propos d'un cas.
Introduction : Le syndrome de Fahr est une entité anatomoclinique rare, associant une calcification des noyaux gris centraux de manière symétrique à un tableau neuropsychiatrique t...
Fahr disease pada pasien polineuropati diabetikum: Laporan kasus
Fahr disease pada pasien polineuropati diabetikum: Laporan kasus
Introduction: Fahr disease is a rare disease that affects less than one in a million people. Calcification in the basal ganglia region is the hallmark of Fahr disease. Genetic muta...
Late-Onset Fahr Disease Presenting with Chronic Vertigo, Right-Sided Postural Instability, and Mild Cognitive Impairment: A Case Report
Late-Onset Fahr Disease Presenting with Chronic Vertigo, Right-Sided Postural Instability, and Mild Cognitive Impairment: A Case Report
Fahr disease, currently recognized within the spectrum of primary familial brain calcification, is a rare neurodegenerative disorder characterized by bilateral intracranial calcifi...
Fahr’s disease presenting with thalamic hemorrhage: a case report
Fahr’s disease presenting with thalamic hemorrhage: a case report
Abstract
Background: Fahr’s disease is a rare neurological disorder which is characterized by diffuse intracranial calcification documented in bilateral basal ganglia and d...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Cataract and Fahr syndrome: A case report
Cataract and Fahr syndrome: A case report
Introduction: Fahr syndrome is a rare neurological disorder associated with abnormal calcium deposits in the brain. Cataract is a rare but potentially disabling complication of Fah...

